Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Neurology (clinical),Neurology
Reference29 articles.
1. Fereshtehnejad, S. M., Zeighami, Y., Dagher, A. & Postuma, R. B. Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression. Brain 140, 1959–1976 (2017).
2. Tambasco, N., Romoli, M. & Calabresi, P. Levodopa in Parkinson’s disease: current status and future developments. Curr. Neuropharmacol. 15, 1–13 (2017).
3. Fahn, S. et al. Levodopa and the progression of Parkinson’s disease. N. Engl. J. Med. 351, 2498–508 (2004).
4. Abbott, A. Levodopa: the story so far. Nature 466, S6–S7 (2010).
5. Calabresi, P. et al. Levodopa-induced dyskinesias in patients with Parkinson’s disease: filling the bench-to-bedside gap. Lancet Neurol. 9, 1106–1117 (2010).
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献